Top Small Cap Negative Movers: TENX: -85% Topline Results from Phase 3 LEVEL Clinical Trial of TNX-103 in Patients with PH-HFpEF MB: -35% Mo
Top Small Cap Negative Movers: TENX: -85% Topline Results from Phase 3 LEVEL Clinical Trial of TNX-103 in Patients with PH-HFpEF MB: -35% Momentum Mover AIRS: -30% Earnings YJ: -27% Momentum Mover SSM: -23% Momentum Mover NABL: -23% Earnings AIOT: -23% Earnings NAMI: -19% Momentum Mover
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.